Oncology clinical trials present unique challenges for collecting, analyzing and interpreting patient-reported outcome (PRO) data.
Join us as our panel of experts discuss these challenges and outline some solutions to overcome them.
- The specific challenges associated with the analysis of data from oncology studies;
- Why traditional statistical methods for clinical trials can lead to biased results when applied to oncology studies;
- Possible analytic methods to help account for potential biases and help you better understand your patients; and
- Why safety and patient-reported outcome endpoints may appear contradictory in oncology trials.